We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-1.89%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$48.4B
AUM Growth
+$1.38B
(+2.9%)
Cap. Flow
+$2.75B
Cap. Flow
% of AUM
5.68%
Top 10 Holdings %
Top 10 Hldgs %
14.42%
Holding
2,432
New
254
Increased
1,140
Reduced
904
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hawaiian Electric Industries
HE
|
+$139M |
| 2 |
GE Aerospace
GE
|
+$128M |
| 3 |
NVIDIA
NVDA
|
+$100M |
| 4 |
Citizens Financial Group
CFG
|
+$99M |
| 5 |
Molson Coors Class B
TAP
|
+$97.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$89.6M |
| 2 |
Booking.com
BKNG
|
+$82.6M |
| 3 |
Domino's
DPZ
|
+$81.9M |
| 4 |
Apple
AAPL
|
+$81.9M |
| 5 |
American International
AIG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.29% |
| 2 | Healthcare | 13.45% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.23% |
| 5 | Financials | 11.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
1726
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $708K | ﹤0.01% |
55,648
-8,373
| -13% | -$116K |
|
|
INFN
1727
DELISTED
Infinera Corporation Common Stock
INFN
| $707K | ﹤0.01% |
169,190
+150,024
| +783% | +$648K |
|
1728
Fate Therapeutics
FATE
$319M
| $706K | ﹤0.01% |
+332,911
| New | +$1.1M |
|
1729
Chesapeake Utilities
CPK
$3.22B
| $704K | ﹤0.01% |
7,201
-1,865
| -21% | -$211K |
|
1730
Merit Medical Systems
MMSI
$5.44B
| $704K | ﹤0.01% |
10,198
-7,549
| -43% | -$543K |
|
|
VTNR
1731
DELISTED
Vertex Energy, Inc
VTNR
| $701K | ﹤0.01% |
157,546
+20,487
| +15% | +$105K |
|
|
BLD
1732
DELISTED
TopBuild
BLD
| $697K | ﹤0.01% |
2,776
-5,655
| -67% | -$1.56M |
|
|
LL
1733
DELISTED
LL Flooring Holdings, Inc.
LL
| $696K | ﹤0.01% |
219,585
+142,894
| +186% | +$514K |
|
1734
Seadrill
SDRL
$2.92B
| $695K | ﹤0.01% |
+15,528
| New | +$723K |
|
1735
Arbor Realty Trust
ABR
$998M
| $695K | ﹤0.01% |
45,798
+66
| +0.1% | +$1.04K |
|
1736
Intapp
INTA
$3.08B
| $694K | ﹤0.01% |
20,707
-18,147
| -47% | -$663K |
|
1737
Carpenter Technology
CRS
$26.7B
| $692K | ﹤0.01% |
10,298
+4,017
| +64% | +$243K |
|
1738
H.B. Fuller
FUL
$3.34B
| $691K | ﹤0.01% |
10,075
-3,995
| -28% | -$282K |
|
|
KRTX
1739
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $691K | ﹤0.01% |
4,084
-1,169
| -22% | -$220K |
|
1740
Dave & Buster's
PLAY
$349M
| $690K | ﹤0.01% |
18,616
-26,375
| -59% | -$1.08M |
|
1741
Renasant Corp
RNST
$3.92B
| $685K | ﹤0.01% |
26,171
+11,464
| +78% | +$323K |
|
1742
Astec Industries
ASTE
$989M
| $685K | ﹤0.01% |
14,535
-5,787
| -28% | -$286K |
|
1743
Axsome Therapeutics
AXSM
$11.1B
| $682K | ﹤0.01% |
9,761
-1,946
| -17% | -$145K |
|
|
CEPU
1744
Central Puerto
CEPU
$2B
| $676K | ﹤0.01% |
+116,191
| New | +$767K |
|
1745
Bridgewater Bancshares
BWB
$605M
| $676K | ﹤0.01% |
71,328
+7,386
| +12% | +$76.1K |
|
1746
PLAYSTUDIOS Inc
MYPS
$81.1M
| $675K | ﹤0.01% |
212,341
+139,321
| +191% | +$553K |
|
1747
Karyopharm Therapeutics
KPTI
$47.6M
| $672K | ﹤0.01% |
33,453
+22,517
| +206% | +$505K |
|
1748
Blackstone
BX
$118B
| $669K | ﹤0.01% |
6,245
+3,690
| +144% | +$384K |
|
1749
Installed Building Products
IBP
$6.63B
| $669K | ﹤0.01% |
5,353
-3,875
| -42% | -$547K |
|
|
RPT
1750
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $664K | ﹤0.01% |
62,832
-475,743
| -88% | -$5.09M |
|
Similar funds
VGA
AQR Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, AQR Capital Management held 2,432 positions worth $48.4B, up 2.9% from $47B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management deployed $2.75B of net new capital in Q3 2023, opening 254 new positions and adding to 1,140 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was CF Industries, an estimated $89.6M trimmed.
- AQR Capital Management's largest Q3 2023 buy was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
- AQR Capital Management added most to Hawaiian Electric Industries in Q3 2023, an estimated $139M increase.
- AQR Capital Management's biggest Q3 2023 reduction was CF Industries, cutting an estimated $89.6M.
- AQR Capital Management fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $60.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $48.4B portfolio in Q3 2023.
- AQR Capital Management opened 254 new positions and closed 123 in Q3 2023.
- AQR Capital Management's portfolio value rose 2.9% quarter-over-quarter to $48.4B.
Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.